# Comparative Analysis of Oral Iron With Injectable Ferric Carboxymaltose for Post Partum Iron Deficiency Anaemia

> **NCT07648628** · PHASE2,PHASE3 · COMPLETED · sponsor: **ESI-PGIMSR, Basaidarapur** · enrollment: 200 (actual)

## Conditions studied

- Anemia
- Anemia, Postpartum
- Iron Deficiency Anemia of Pregnancy
- Iron Deficiency Anemia Treatment
- FCM

## Interventions

- **DRUG:** Ferric Carboxymaltose (FCM)

## Key facts

- **NCT ID:** NCT07648628
- **Lead sponsor:** ESI-PGIMSR, Basaidarapur
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2025-07-05
- **Final completion:** 2025-08-16
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07648628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07648628, "Comparative Analysis of Oral Iron With Injectable Ferric Carboxymaltose for Post Partum Iron Deficiency Anaemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07648628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*